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The term ‘‘the DNA damage response’’ (DDR)
encompasses a sophisticated array of cellular ini-
tiatives set in motion as cells are exposed to DNA-
damaging events. It has been known for over half
a century that all organisms have the ability to
restore genomic integrity through DNA repair.
More recent discoveries of signal transduction
pathways linking DNA damage to cell cycle arrest
and apoptosis have greatly expanded our views
of how cells and tissues limit mutagenesis and tu-
morigenesis. DNA repair not only plays a pivotal
role in suppressing mutagenesis but also in the re-
versal of signals inducing the stress response. If
repair is faulty or the cell is overwhelmed by dam-
age, chances are that the cell will despair and be
removed by apoptosis. This final fate is deter-
mined by intricate cellular dosimeters that are yet
to be fully understood. Here, key findings leading
to our current view of DDR are discussed as
well as potential areas of importance for future
studies. Environ. Mol. Mutagen. 51:879–889,
2010. VC 2010 Wiley-Liss, Inc.
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HISTORYOF THE DDR RESEARCH FIELD
Long before it was determined that DNA is the basic
repository of the genetic material of all life, Hermann
Muller realized that environmental agents, such as X-rays,
induce mutations [Muller, 1927]. Subsequently, Alexander
Hollaender discovered that cells have the innate ability to
recover from damage induced by UV light and realized
that cellular responses must exist that transiently arrest
the growth of exposed cells, allowing them time to repair
the damage before resuming growth [Hollaender and Cur-
tis, 1935; Hollaender and Duggar, 1938]. Discoveries of
various DNA repair pathways during the second part of
the 20th century explained many of these early observa-
tions in mechanistic terms. However, it was not until the
discovery of DNA damage-induced signal transduction
pathways during the 1990s that we began to understand
the full meaning of the DNA damage response (DDR).
In Figure 1, some of the key findings in the DDR field
are summarized in a time line. It should be noted that
there is never a single finding or publication that truly
defines a new discovery but rather all discoveries build on
the accumulated knowledge up to that point. Therefore,
any attempts to single out individual publications as ‘‘the
discovery’’ are inherently flawed and I apologize for leav-
ing out many important contributions from this time line.
Nevertheless, the intellectual building blocks of our field
listed in this timeline are astonishing and one may ask
what new discoveries are yet to be made?
COMPONENTS OF DDR
The DDR is a comprehensive and complex set of
responses aimed at safeguarding the genomic integrity of
cells [Jackson and Bartek, 2009]. DNA repair processes
lay the foundation of this response with added layers of
monitoring leading to the activation of cell cycle check-
points or apoptosis (Fig. 2). The cellular fate of promot-
ing either survival or death is governed by the severity of
damage, the efficiency of repair, and is strongly depend-
ent on cell type [Gudkov and Komarova, 2003].
DNA Repair
DNA repair is arguably the most important component
of DDR. The DNA restoration task of the various DNA
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repair enzymes is enormous considering that the DNA
molecule is not unusually stable and is further damaged
by endogenous reactive oxygen species and by the wear
and tear of replication and transcription. It has been esti-
mated that more than 20,000 lesions are induced on a
daily basis in each cell by endogenous forces [Friedberg
et al., 2006]. Adding all these events up in one individual,
one would get a number that is larger than there are
grains of sand on all the beaches of this planet [Der-
heimer, 2007]. The great majority of the endogenously
induced lesions are repaired by the base excision repair
(BER) machinery and loss of any of the BER enzymes
APE1 [Xanthoudakis et al., 1996], DNA polymerase b
[Gu et al., 1994] or DNA ligase III [Puebla-Osorio et al.,
2006] is not compatible with life.
DNA repair enzymes are constantly engaged in probing
the integrity of the DNA molecule. In general, there
does not seem to be a need for additional DNA damage
sensors, such as ataxia telangiectasia mutated (ATM) and
ATM and RAD3-related (ATR), to directly activate the
DNA repair pathways. However, some examples exist in
which ATM or ATR-mediated phosphorylation stimulates
repair. For example, it has been shown that ATR pro-
motes repair after UV-irradiation by phosphorylating the
nucleotide excision repair (NER) protein XPA [Wu et al.,
2006; Shell et al., 2009] or stimulating global genomic
repair in S-phase [Auclair et al., 2008]. Furthermore,
ATM promotes repair in heterochromatin following expo-
sure to ionizing radiation [Beucher et al., 2009; Goodarzi
et al., 2008; Noon et al., 2010]. Finally, by phosphoryl-
ating and activating p53, ATM and ATR promote global
genomic nucleotide excision repair [Ford and Hanawalt,
1995, 1997] by the induced expression of DNA repair
genes such as p48 (DDB2) [Hwang et al., 1999] and XPC
[Adimoolam and Ford, 2002] (Fig. 2). Conversely, DNA
repair intermediates formed by NER trigger the activation
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Fig. 1. Timeline of major discoveries in the DDR field. The discoveries
listed on top are related to various effects of DNA damage on cellular func-
tions and DNA damage signaling while the discoveries listed on the bottom
are related to DNA repair. The numbers in parentheses denote the dis-
covery’s corresponding publications, which are listed below: (1) [Muller,
1927]; (2) [Hollaender and Curtis, 1935]; (3) [Dulbecco, 1949; Kelner,
1949]; (4) [Watson and Crick, 1953]; (5) [Kanazir and Errera, 1954]; (6)
[Rupert et al., 1958]; (7) [Beukers and Berends, 1960]; (8) [Kameyama and
Novelli, 1962; Masters and Pardee, 1962]; (9) [Boyce and Howard-Flan-
ders, 1964; Pettijohn and Hanawalt, 1964; Rasmussen and Painter, 1964;
Setlow and Carrier, 1964]; (10) [Holliday, 1964]; (11) [Rupp and Howard-
Flanders, 1968]; (12) [Cleaver, 1968]; (13) [Kerr et al., 1972]; (14) [Lin-
dahl, 1974]; (15) [George et al., 1974; Witkin, 1974]; (16) [Wagner and
Meselson, 1976]; (17) [Jeggo et al., 1977; Samson and Cairns, 1977]; (18)
[Lane and Crawford, 1979; Linzer and Levine, 1979]; (19) [Wilson et al.,
1982]; (20) [Mellon et al., 1987]; (21) [Kastan et al., 1991]; (22) [Kastan
et al., 1992]; (23) [Walworth et al., 1993]; (24) [Lowe et al., 1993]; (25)
[Ljungman and Zhang, 1996]; (26) [Matsuoka et al., 1998]; (27) [Johnson
et al., 1999; Masutani et al., 1999a, b]; (28) [Tibbetts et al., 1999]; (29) [de
Boer et al., 2002]; (30) [Bartkova et al., 2005; Gorgoulis et al., 2005]; (31)
[Matsuoka et al., 2007]. [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
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of ATR leading to the phosphorylation of the histone
variant H2AX (gH2AX) [Hanasoge and Ljungman, 2007].
Cell Cycle Checkpoints
Proliferating cells are in general much more susceptible
than resting cells to the toxic and mutagenic effects of
DNA-damaging agents. This is due to the formidable
tasks of DNA replication and chromosome segregation,
processes easily derailed by DNA damage. To prevent
cells with damaged DNA to enter S-phase or mitosis,
ATM and ATR phosphorylate specific substrates, such as
p53, CHEK1, and CHEK2, which promote cell cycle
arrest [Reinhardt and Yaffe, 2009]. This arrest will
‘‘buy’’ time for the repair enzymes to clean up the DNA
before DNA synthesis or chromosome segregation begin.
In addition to setting up cell cycle checkpoints, ATM
regulates the recruitment of a number of DDR factors to
sites of some types of DNA damage, e.g., DNA double
strand breaks (DSB), by the phosphorylation of H2AX
(Fig. 3). This phosphorylation nucleates the formation of
a large complex consisting of MDC1, which binds to
phosphorylated H2AX and in turn allows ubiquitin ligase
RNF8 to bind. RNF8 then ubiquitylates histones in the
chromatin surrounding the damage, thereby recruiting
BRCA1 via the RAP80 protein and 53BP1 via chromatin
structure alterations [Huyen et al., 2004]. When
assembled, this complex enhances DNA double strand
break repair, partakes in activating cell cycle arrest and
increases resistance to radiation [Yan and Jetten, 2008]. It
has been recently shown that following UV-irradiation,
DNA repair intermediates may trigger formation of
gH2AX [Hanasoge and Ljungman, 2007] and the assem-
bly of a DDR complex containing MDC1 and RNF8
[Marteijn et al., 2009]. While inactivation of some of the
components in this complex, such as RNF8, resulted in
increased sensitivity of cells to UV light, DNA repair was
not affected. It is possible that the DDR complexes form-
ing after the induction of DNA repair intermediates play
a role in restoring the chromatin structure following repair
to allow for resumption of transcription and/or replication.
Another protein that is recruited to the multiprotein
DDR complex is the DNA methyltransferase DNMT (Fig.
3). This enzyme methylates nearby CpG islands to inacti-
vate any ongoing transcription that may interfere with
repair [O’Hagan et al., 2008]. Interestingly, the removal
of the DNA methylation following repair was found not
to be fully complete which may result in the epigenetic
silencing of genes, including tumor suppressor genes.
Thus, genotoxic damage may contribute to carcinogenesis
by altering either the genome or the epiginome.
As repair continues, the pool of activated ATM or
ATR will diminish to a level that finally will allow the
traffic light to turn green and the cells can resume pro-
gression of the cell cycle. Although the mechanisms regu-
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Fig. 2. The DNA damage response. The ATM kinase responds to alter-
ations in DNA/chromatin topology while the ATR kinase monitors inter-
ruptions in transcription and replication as well as responds to DNA
repair intermediates induced during NER. The induced ‘‘phosphonome’’
involves more than 700 substrates including p53 that collectively pro-
mote cell cycle arrest, DNA repair and/or apoptosis depending on the ef-
ficiency of DNA repair and on cell type. DNA repair can work in ATM/
ATR-dependent and -independent ways to restore DNA integrity and to
reverse DDR signaling. [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
Fig. 3. Formation of a DDR complex at site of DNA DSB. A DSB
induces a topological alteration in the DNA/chromatin that leads to the
activation of ATM and the C-terminal tail of H2AX becomes available
for phosphorylation by ATM. Phosphorylation of H2AX then trigger the
assembly of a large DDR complex consiting of MDC1, RNF8 BRCA1,
53BP1, and DNMT (see text for details). It has been recently shown that
a similar DDR complex containing MDC1 and RNF8 assemble on chro-
matin following UV-irradiation and that DNA repair intermediates may
trigger such assembly. The precise function of these DDR complexes is
not well established but they may give cells the option to utilize recom-
bination for repair, induce cell cycle checkpoints and may play a role in
the restoration of chromatin structure following repair. [Color figure can
be viewed in the online issue, which is available at wileyonlinelibrary.
com.]
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lating the activation and deactivation of cell cycle check-
points are fairly well understood [Reinhardt and Yaffe,
2009; Toettcher et al., 2009], it is not fully clear whether
checkpoints act as binary on/off switches determined by
some critical level of DNA damage or whether cell pro-
gression continues but is slowed down in a DNA damage
dose-dependent manner.
Apoptosis
Apoptosis is the last resort mode for cells if repair of
DNA damage is slow or incomplete. Cells appear to
possess an internal ‘‘apoptotic clock’’ or ‘‘timer’’ which
is set to activate caspases leading to the induction of apo-
ptosis when the remaining time on the timer runs out.
Cells can evidently reset the timer before it runs out if
sufficient DNA repair has occurred and essential proc-
esses such as transcription or replication have resumed.
In 1993, Scott Lowe et al. showed that radiation-
induced apoptosis was strongly dependent on p53 in thy-
mocytes [Lowe et al., 1993]. This led to the hypothesis
that p53 is the master regulator of apoptosis and therefore,
tumors with mutant p53 may respond poorly to radiation
or chemotherapy. It is now clear that the role of p53 in
regulating apoptosis is very cell type specific [Gudkov
and Komarova, 2003] and that p53 may actually protect
certain types of cells against UV light and cisplatin
[McKay and Ljungman, 1999; McKay et al., 2000, 2001].
While apoptosis induced by certain agents such as UV
light, cisplatin, or photoactivated psoralen, is strongly cor-
related to blockage of transcription [Derheimer et al.,
2009; Ljungman and Zhang, 1996; Ljungman et al.,
1999], cells appear to preferentially undergo apoptosis
when attempting to traverse the S-phase of the cell cycle
[McKay et al. 2001, 2002; Derheimer et al., 2009]. How
can apoptosis correlate to both blocked transcription and
to the traversing of S-phase? It is likely that during nor-
mal replication, a mechanism is in place to clear replicons
to be replicated from ongoing transcription to avoid con-
flicts between transcription and replication [Tuduri et al.,
2009] (Fig. 4). In fact, it has been shown that active tran-
scription factories do not generally occupy the same chro-
matin regions as active replication factories [Wei et al.,
1998]. The retinoblastoma protein (Rb) [Ahlander et al.,
2008], the minichromosome maintenance (MCM) proteins
[Bailis and Forsburg, 2004], and the ATR kinase [Cha
and Kleckner 2002; Brown and Baltimore, 2003] may
play roles during S-phase ensuring that replication origins
only fire when transcription has been moved out of the
path. In addition, cells lacking DNA topoisomerase I
induce high levels of gH2AX in active genes during S-
phase, suggesting that DNA topoisomerase I normally
plays a role in suppressing any interference occurring by
transcription during replication [Tuduri et al., 2009]. It is
tempting to speculate that the ‘‘replication stress’’ that
activated oncogenes induce in cells is due to a lax com-
munication between replication and transcription prior to
origin firing resulting in a tug-a-war between transcription
and replication factories.
A similar situation may occur when the transcription
elongation machinery encounters blocking DNA lesions
as cells commit to entering S-phase [Ljungman and Lane,
2004; Tuduri et al., 2009].
DDR AND GENE EXPRESSION
An important outlet of DDR is to modify gene expres-
sion so that cells can better counteract the deleterious
effects of genotoxic exposures and to adapt to potential
future insults [Fornace et al., 1988; Herrlich et al., 1992].
The expression of many genes is upregulated at the level
of transcription by p53-mediated transactivation [El-Deiry
et al., 1993; Zhao et al., 2000], but gene expression may
also be regulated post-transcriptionally through alternative
splicing [Munoz et al., 2009], stabilization of specific
mRNAs [Jackman et al., 1994; Blattner et al., 2000;
Wang et al., 2000], and by preferential translation of cer-
tain mRNAs [Lu et al., 2006b; Kumaraswamy et al.,
2008; Braunstein et al., 2009] (Fig. 5). Some of these
mRNAs are regulated by microRNAs, which can be
induced or repressed after exposure to DNA damage
[Pothof et al., 2009; Shin et al., 2009; Simone et al.,
2009].
What regulates gene expression at all these levels? The
ATM kinase is one of the first responders following expo-
sure to ionizing radiation and it has been shown that
ATM can phosphorylate over 700 substrates after becom-
ing activated [Matsuoka et al., 2007]. The largest group
of proteins phosphorylated by ATM is a group of proteins
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Fig. 4. Tug-A-War between replication and transcription. It is likely
that initiating replication factories must negotiate with nearby transcrip-
tion units to ‘‘finish up’’ so that replication origins can be fired. Many
proteins regulate the timing of replication firing such as Rb, MCM, ATR
and Topo I (see text for details). If transcription units are stalled at DNA
lesions and replication initiates or if activated oncogenes drive cells into
S-phase prematurely, cells will experience ‘‘replication stress’’ activating
DDR. [Color figure can be viewed in the online issue, which is available
at wileyonlinelibrary.com.]
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involved in regulating ‘‘RNA metabolism’’ such as tran-
scription, splicing, mRNA stability and translation. Only
for a few of these proteins, such as p53, has the effect of
ATM phosphoylation on gene expression been clarified
(Fig. 4). There are many proteins known to regulate
mRNA stability by binding to 30UTR sequences. Some of
these RNA-binding proteins are regulated by DNA dam-
age including HuR [Abdelmohsen et al., 2007; Lafarga
et al., 2009], nucleolin [Zhang et al., 2006], RNPC1 [Shu
et al., 2006], and AUF [Lal et al., 2006]. It is not known
whether ATM is involved in the regulation of mRNA sta-
bility or translation via these RNA-binding proteins.
EVOLUTIONOFDDR
During evolution, genomic instability promoted diver-
sity, thereby ensuring a greater probability of survival for
at least some offspring if the environment suddenly
changed. As organisms evolved more complex genomes,
however, genomic instability became mostly detrimental
and systems safeguarding the integrity of DNA became in
demand. While most DNA repair systems found in higher
organisms also exist in lower eukaryotes and bacteria
[Friedberg et al., 2006], higher eukaryotes are equipped
with additional layers of defense systems suppressing mu-
tagenesis and tumorigenesis. Cell cycle checkpoints, regu-
lated by an intricate network of sensors, transducers and
mediators, allow cells more time for repair before enter-
ing replication or mitosis [Reinhardt and Yaffe, 2009;
Toettcher et al., 2009]. Furthermore, the expression of
many DDR genes is induced following DNA damage
leading to enhanced DNA damage surveillance, repair and
apoptosis.
As natural selection rewards improvements in biochem-
ical processes that increase survival, such as DNA repair
and cell cycle checkpoints, how could a genetic program
carrying instructions for cellular suicide be allowed to de-
velop during evolution? The process of apoptosis has an
important role during development and normal tissue ho-
meostasis for the elimination of altered cells or cells that
are not longer needed [Cotter, 2009]. During the course
of evolution, this programmed cell death pathway became
incorporated into DDR to eliminate cells that had sus-
tained damage exceeding their repair capacity [Norbury
and Zhivotovsky, 2004]. To counterbalance apoptosis, cell
cycle checkpoint mechanisms evolved that allowed cells
more time to repair before entering critical cell cycle
stages in which DNA damage may lead to cell death. The
balance between pathways promoting survival and path-
ways promoting death must be finely regulated as to sup-
press cancer but promote longevity [Ljungman and Lane,
2004].
CELLULAR DNADAMAGE DOSIMETERS
How do cells determine the severity of an insult
acquired by a genotoxin to formulate a decision on
whether to induce cell cycle checkpoints and DNA repair
or induce apoptosis? The assessment of the level of DNA
damage is not trivial for a cell since the genome is vast
in molecular terms and it is decorated with histones and
numerous chromatin-binding proteins limiting accessibil-
ity of the lesions to be detected. Cells may assess the se-
verity of the acquired DNA damage in multiple ways.
First, cells may monitor the activity of DNA repair fac-
tors operating on DNA lesions or the level of DDR fac-
tors assembled in nuclear foci. If a certain critical level of
DNA repair activity or DDR occupancy at nuclear foci is
achieved, a strong enough signal surpassing a particular
threshold may be generated triggering apoptosis. How the
cell might monitor repair activity or foci occupancy is
unknown.
Second, dedicated DNA damage sensors activated at
sites of DNA damage may transmit stress signals as long
as some minimal level of DNA lesions persists. This sig-
nal may be amplified in a ‘‘feed-forward’’ cascade putting
time pressure on cells to expeditiously repair the DNA
lesions before a critical level of signal is reached. If the
damage is severe, cells may not be able to keep up with a
progressively increasing damage signal with cell death to
ensue.
Third, as discussed above, cells may monitor processes
that normally operate on DNA, such as transcription and
replication, to gather information on the status of the
DNA template. If lesions in the DNA template interrupt
transcription and/or replication, DNA damage signals may
be generated in proportion to the overall severity of the
interruption. We and others have shown that blockage of
transcription is linked to the accumulation of p53 [Yamai-
zumi and Sugano, 1994; Ljungman et al., 1999] and that
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Fig. 5. Radiation induces alterations in gene expression at multiple lev-
els. ATM is activated by ionizing radiation leading to the phosphoryla-
tion of many downstream substrates resulting in the regulation of gene
expression and protein function on many different levels (see text for
details). [Color figure can be viewed in the online issue, which is avail-
able at wileyonlinelibrary.com.]
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blockage of transcription elongation in particular gener-
ates an ATR-dependent stress response resulting in p53
phosphorylation [Derheimer et al., 2007; Ljungman et al.,
2001]. Induction of p53 may then trigger apoptosis de-
pendent on the cell type [Gudkov and Komarova, 2003].
Fourth, extended transcription blockage leads to the
induction of apoptosis [Ljungman and Zhang, 1996] per-
haps by the loss of particular RNAs coding for critical
survival-promoting proteins. One example is the loss of
the apoptosis antagonist Mcl-1 as a result of UV-mediated
transcription blockage leading to apoptosis [Nijhawan
et al., 2003]. Alternatively, inhibition of transcription may
lead to the loss of a protein(s) involved in the processes
of transcription or translation itself. This scenario would
paint the cell into a corner where it would run out of any
possibility of regenerating the missing essential protein(s)
or any other protein for that matter. This would represent
a point-of-no-return in which the cell is doomed and ulti-
mately would be eliminated.
DDR, CANCER, ANDAGING
DDR has been proposed to act as a major barrier for
tumorigenesis by activating cell cycle checkpoints, apo-
ptosis or senescence as a result of oncogene-induced
‘‘replication stress’’ [Bartkova et al., 2005, 2006; Gorgou-
lis et al., 2005]. This puts selective pressure on precancer-
ous lesions and favors clones that have obtained muta-
tions in DDR genes for continued proliferation. In addi-
tion to allowing these cells to proliferate, such mutations
are also critical for creating a ‘‘mutator phenotype’’ that
will accelerate the process of carcinogenesis by promoting
genetic instability [Loeb et al., 2003]. Oncogene-mediated
replication stress and defects in DDR in cancer cells are
promising new areas for cancer therapeutic exploitation
[Helleday et al., 2008; Ljungman, 2009].
While individuals with inactivating mutations in DDR
pathways are profoundly susceptible for cancer, individu-
als with certain genetic polymorphisms, epigenetic silenc-
ing or heterozygosity in DDR genes also have elevated
risks for contracting cancer. For example, about 1% of
the population is estimated to be heterozygotic for the
ATM allele, leading to haploinsufficiency and an elevated
risk for cancer [Spring et al., 2002; Thompson et al.,
2005; Lu et al., 2006a]. Furthermore, ATM alleles are
found to be frequently mutated or epigenetically inacti-
vated in cancer, suggesting that selective pressure favors
inactivation or haploinsufficiency of ATM and the DDR
pathway [Vo et al., 2005]. Similarly, heterozygosity of
p53 [Srivastava et al., 1990], BRCA1/2 [Venkitaraman,
2002] or mismatch repair genes [Jiricny and Nystrom-
Lahti, 2000] leads to familial predisposition to cancer.
The aging process has been linked to the accumulation
of endogenous lesions in the genome [Hoeijmakers,
2009]. In particular, lesions interfering with transcription
appear to be the major type of lesion associated with the
aging process and ‘‘premature aging’’ syndromes caused
by certain DNA repair defects [Ljungman and Zhang,
1996; de Boer et al., 2002; Garinis et al., 2009]. The gene
expression profiles from cells of old individuals differ
from those of younger individuals and interestingly, when
cells from young mice are UV-irradiated, their expression
profile changes so that it resemble the profile of cells
from older mice [Garinis et al., 2009]. Since UV light
randomly introduces transcription-blocking lesions in the
genome, large genes are predicted to be inactivated more
easily while small genes are less effected by UV light
[McKay et al., 2004; Sauerbier and Hercules, 1978].
Thus, it is possible that genes not needed later in life,
such as the insulin growth factor 1 receptor (IGF-1R),
may have been selected to reside in large transcription
units that have a high likelihood of becoming inactivated
over time by random transcription-blocking lesions. Cor-
respondingly, genes needed throughout life may be more
compact so as to avoid being inactivated. It is also possi-
ble that repair mechanisms may be programmed to selec-
tively remove lesions from genes important for longevity
but evidence for such selective repair is lacking.
FUTURE STUDIES OF DDR
Studies of DNA repair dominated the DDR field during
the 1960s, 1970s, and 1980s, while explorations of DNA
damage signaling, cell cycle checkpoints, and apoptosis
have blossomed during the last 20 years. We are in a very
exciting period where technological advances in DNA
sequencing, mass spectrometry, crystallography, and mi-
croscopy make it possible to comprehensively interrogate
the genome, the epiginome, the RNAome, the proteome, the
phosphonome and many other ‘‘omes’’ and how protein
complexes are assembled and where in cells they operate.
What are the biggest questions in the field that may be
answered in the next 5–10 years? Here is my personal top
ten list:
10. How is DNA topology and chromatin structure
restored following DNA repair? DNA of eukaryotic
cells contains localized domains of unconstrained
supercoiling that is assumed to be lost following
induction of DNA strand breaks [Ljungman and
Hanawalt, 1992, 1995]. Following the repair of a
DNA strand break, the cells need to restore DNA to-
pology and chromatin structure to completely restore
the intact genomic region and for transcription or rep-
lication to resume [Ljungman, 2005]. How these
events occur are not well understood but studies have
suggested that p53 [McKay and Ljungman, 1999;
McKay et al., 2000] and the DDR complex consisting
Environmental and Molecular Mutagenesis. DOI 10.1002/em
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of MDC1 and RNF8 [Marteijn et al., 2009] may play
important roles in restoring the chromatin structure
and to allow resumption of transcription following
repair.
9. What is a DDR nuclear focus and why are so many
proteins aggregating in one place? Following induc-
tion of a double strand break, long stretches of H2AX
on either side of the break are phosphorylated, provid-
ing a ‘‘landing strip’’ for DDR proteins. Although
only a few of the recruited DDR proteins will eventu-
ally be directly involved in the repair of the lesions,
why is there such an excess of these proteins aggregat-
ing near the break site? Is the formation of this landing
strip merely a mechanism to increase the local concen-
tration of proteins that may be needed in the repair?
Does this local accumulation act as a dosimeter of the
severity of the damage and an indicator of the kinetics
of recovery or is it needed for the restoration of chro-
matin structure following repair?
8. How do translesion DNA polymerases kick out proces-
sive polymerases during translesion DNA synthesis?
When DNA polymerases encounter certain DNA
lesions in the DNA template, translesion DNA poly-
merases replace the processive DNA polymerases
[Friedberg et al., 2005]. This process depends on the
coordination of many factors to induce ubiquitylation
of PCNA at stalled replication forks. Does the
exchange take place on either the leading or lagging
strand? What happens to the released processive poly-
merase? To what extent is this process altered in can-
cer cells?
7. How do replication and transcription communicate
with each other to avoid ‘‘tug-a-war’’ conflicts during
S-phase? Little is known about how replication negoti-
ates with transcription to clear transcription factories
from the path of DNA to be replicated. Many proteins
are involved in regulating the initiation and elongation
of replication but it is not known whether they com-
municate with transcription (Fig. 4). Do DNA methyl
transferases (DNMTs) methylate CpG islands of genes
to be inactivated when they are in the path of replica-
tion? Does the presence of transcription factories
stalled at sites of UV-lesions introduce a particularly
difficult challenge when located on the same stretch of
DNA as the replication machinery [McKay et al.,
2002; Derheimer et al., 2009]?
6. Have the sizes of genes been selected to allow for dif-
ferential expression after UV light and as part of an
aging program? As discussed above, transcription-
blocking lesions accumulate in DNA over time leading
to the inactivation of genes [Garinis et al., 2009]. The
degree of inhibition would be influenced by the size of
the gene with large genes expected to have a higher
probability of attracting blocking lesions [McKay
et al., 2004]. Therefore, do genes that are not needed
later in life reside in larger transcription units than
genes that are in demand at old age?
5. How does the apoptotic timer work and what do cells
use as dosimeters for DNA damage? As shown in Fig-
ure 2, DDR signaling can lead to multiple outcomes,
such as enhanced repair, activation of cell cycle check-
points or apoptosis. It is not well understood what reg-
ulates the choice of these very different outcomes but
cells must rely on molecular dosimeters and timers
that have different settings in different cell types.
4. What are the mechanisms leading to oncogene-induced
‘‘replication stress’’? Overexpression or activation of
oncogenes forces cells to prematurely enter S-phase
resulting in ‘‘replication stress’’ [Bartkova et al., 2005;
Gorgoulis et al., 2005]. This stress activates many
DDR proteins suggesting that DNA damage is induced
when oncogenes are activated. Does expression of
oncogenes force cells to fire replication origins before
the path is cleared of transcription and may this be the
cause of replication stress [Tuduri et al., 2009]? If we
knew the nature of this damage and the factors the cell
utilizes to overcome this stress, we may identify new
therapeutic targets that tumor cells uniquely rely upon.
3. How do DNA-damaging agents affect transcription,
mRNA stability and translation? As described in
Figure 5, ATM and ATR phosphorylate numerous
proteins involved in RNA metabolism and thus may
regulate DNA damage-induced/repressed transcription,
RNA splicing, mRNA stability and translation via
these proteins. Next generation sequencing technolo-
gies will make it possible to comprehensively assess
the RNAome, RNA splicosome, transcriptome, RNA
‘‘stabilome’’ and ‘‘translatome’’ and the effect DNA
damage may have on these ‘‘omes.’’
2. How is DNA damage sensed and how are ATM and
ATR activated? We have learned that ATM respond to
topological alterations in DNA/chromatin [Bakkenist
and Kastan, 2003] and that ATR monitors replication
[Guo et al., 2000; Hekmat-Nejad et al., 2000], tran-
scription [Derheimer et al., 2007] and DNA repair
intermediates [Hanasoge and Ljungman, 2007; Mar-
teijn et al., 2009]. However, the molecular mechanisms
by which such sensing and monitoring are accom-
plished are not fully understood.
1. How can we best translate the knowledge in the DDR
field into new therapies? There is a growing knowl-
edge of how to explore targets in the DDR pathway
for novel cancer therapies [Helleday et al., 2008;
Ljungman, 2009]. Some exciting new therapies include
the targeting of PARP1 in HR-defective cancers
[Bryant et al., 2005; Farmer et al., 2005] and the tar-
geting CHEK1 in p53-mutated cancers [Chen et al.,
2006; Blasina et al., 2008]. The simultaneous targeting
of DDR pathways to which cancer cells are ‘‘ad-
dicted’’ would be effective, especially in combina-
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tion with radiation or chemotherapy. Furthermore, the
reestablishment of DDR growth barriers in tumors that
have lost them may prove to be a powerful and selec-
tive way to target tumor cells for elimination.
The DDR field has made some extraordinary advances
over the last 50 years. We are now in a good position to
translate some of this vast knowledge into clinical thera-
pies to prevent and treat human diseases such as cancer
and perhaps aging. However, our knowledge is still lim-
ited and many breakthroughs in the DDR field that will
impact public health are waiting to be made. Thus, it is
of great importance to strengthen the support of basic
research to attract and sustain bright scientists working in
this exciting and important field.
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